Where can I buy Sotoraxibu in Hainan?

Sotorasib (AMG510), also known as Sotorasib, is a new type of anti-cancer drug that is a KRAS G12C inhibitor. The drug works by targeting a common cancer mutation, the KRAS G12C mutation, which is widespread in a variety of cancers, including lung, colorectal and other solid tumors.

Sotorasibu is currently not available for purchase in the domestic market because it has not yet obtained domestic marketing approval. Therefore, patients who need the drug must turn to overseas sources to purchase it. The overseas market for sotoraxib includes expensive original drugs and relatively affordable generic drugs. Original drugs mainly come from Europe and Hong Kong, China, and cost tens of thousands, which is a heavy burden for many patients.

The good news, however, is that more affordable generic drug options also exist in foreign markets, such as those in Laos. Recently, the prices of two major generic drug brands, Lao Lucius and Lao Daxiong, have dropped significantly and can now be purchased for only more than one thousand to two thousand yuan, which greatly reduces the financial pressure on patients. It is worth mentioning that these generic drugs are basically the same as the expensive original drugs in terms of pharmaceutical ingredients.

Sotorasiib works by inhibiting the activity of the KRAS G12C mutated protein, which promotes the growth and spread of tumor cells. By binding to the KRAS G12C protein, sotoraxib blocks its normal signaling pathway, thereby inhibiting the proliferation and survival of tumor cells.

Clinical trials have shown that sotoraxib exhibits significant anti-tumor activity in the treatment of KRAS G12C mutated lung cancer patients. The study results showed that the drug was not only well tolerated in patients with advanced lung cancer, but also showed significant efficacy in patients whose tumors had progressed despite previous treatment regimens.

Soteracib generally exhibits fewer toxic side effects than many chemotherapy drugs, making it a preferable treatment option. However, some patients may experience mild adverse reactions such as nausea, fatigue, and changes in taste. Therefore, when using this drug, doctors need to closely monitor patients and make adjustments based on the patient's specific situation.